Chinese Antibiotic Makers To Explore Overseas Markets
This article was originally published in PharmAsia News
Antibiotic producers in China including Sichuan Kelun Pharmaceutical, Qilu Pharmaceutical, Harbin Pharmaceutical and United Laboratories International, are increasing production capacity of antibiotics and exploring overseas markets such as the U.S., the EU, Japan, Australia, Brazil, Russia, among others
You may also be interested in...
GSK achieved a first-in-class market oncology launch in 2020, but will have to increase that hit rate in order to fulfil its blockbuster ambitions.
The two companies can now market their HER-2 targeting antibody-drug conjugate in its second tumor type as they look to expand beyond breast cancer.
Coronavirus Notebook: EMA Data Hack Aimed At 'Undermining Trust' In Vaccines, Russia Plans EU Sputnik V Filing Next Month
France has reported on side-effect reports concerning the Pfizer/BioNTech vaccine, and the World Health Organization has warned that plans to provide global equitable access to coronavirus vaccines are at risk.